CleanSpace Holdings Ltd. (AU:CSX)
ASX:CSX
Top Page
CleanSpace Holdings Ltd.
(Sydney:CSX)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.45
▼(-33.24% Downside)
Action:ReiteratedDate:11/28/25
CleanSpace Holdings Ltd. is currently facing significant financial and technical challenges. The most impactful factors are the ongoing profitability issues and weak cash flow performance, compounded by bearish technical indicators. The negative P/E ratio and lack of dividend yield further detract from the stock's valuation appeal. Overall, the stock's outlook is cautious, with financial instability and negative market momentum being the primary concerns.
Positive Factors
High gross profit margin
A 74.76% gross margin indicates durable unit-level profitability from product design and cost control. High product margins provide room to absorb SG&A or R&D investments and support future operating leverage as revenue scales, improving long-term earnings potential.
Negative Factors
Negative profitability metrics
Sustained negative net and EBIT margins and a negative ROE mean the business currently destroys shareholder capital. This constrains internal reinvestment, forces external capital reliance, and undermines long-term shareholder returns until structural profitability is restored.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross profit margin
A 74.76% gross margin indicates durable unit-level profitability from product design and cost control. High product margins provide room to absorb SG&A or R&D investments and support future operating leverage as revenue scales, improving long-term earnings potential.
Read all positive factors
CleanSpace Holdings Ltd. (CSX) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$37.11M
Dividend YieldN/A
Average Volume (3M)39.59K
Price to Earnings (P/E)7.2
Beta (1Y)0.35
Revenue Growth25.72%
EPS Growth84.69%
CountryAU
Employees55
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)0.02
Shares Outstanding78,949,590
10 Day Avg. Volume29,005
30 Day Avg. Volume39,591
Financial Highlights & Ratios
PEG Ratio1.00
Price to Book (P/B)2.11
Price to Sales (P/S)2.05
P/FCF Ratio40.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)AU$23.10M
CleanSpace Holdings Ltd. Business Overview & Revenue Model
Company Description
CleanSpace Holdings Limited engages in the design, manufacture, and sale of respirators and related products and services for healthcare and industrial employers worldwide. It offers CleanSpace HALO, a personal respiratory protection for healthcar...
How the Company Makes Money
CleanSpace generates revenue primarily from selling its respiratory protection products, led by CleanSpace-branded PAPR devices and associated accessories (e.g., masks/facepieces, hoses, chargers, carrying components). A meaningful portion of earn...
CleanSpace Holdings Ltd. Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.66M | 19.76M | 15.72M | 12.09M | 13.36M | 49.93M |
| Gross Profit | 9.47M | 14.78M | 11.36M | -5.16M | 9.75M | 40.27M |
| EBITDA | -1.07M | -824.55K | -3.49M | -10.55M | -14.10M | 17.15M |
| Net Income | 1.76M | -478.28K | -3.13M | -8.13M | -11.28M | 11.39M |
Balance Sheet | ||||||
| Total Assets | 26.92M | 27.57M | 26.05M | 28.98M | 38.36M | 50.72M |
| Cash, Cash Equivalents and Short-Term Investments | 9.83M | 10.47M | 9.76M | 12.16M | 24.30M | 38.24M |
| Total Debt | 2.89M | 4.54M | 3.45M | 4.00M | 4.13M | 4.38M |
| Total Liabilities | 5.62M | 8.41M | 6.95M | 7.02M | 8.60M | 9.99M |
| Stockholders Equity | 21.30M | 19.16M | 19.10M | 21.96M | 29.75M | 40.73M |
Cash Flow | ||||||
| Free Cash Flow | 1.78M | 1.01M | -1.76M | -11.97M | -13.60M | 11.73M |
| Operating Cash Flow | 1.95M | 1.11M | -1.73M | -11.96M | -13.00M | 13.46M |
| Investing Cash Flow | -1.17M | -778.38K | 2.00M | 7.06M | -628.00K | -14.18M |
| Financing Cash Flow | -461.86K | -559.87K | -637.10K | -211.49K | -357.95K | 16.19M |
CleanSpace Holdings Ltd. Technical Analysis
Negative
0.68
Price Trends
0.56
Negative
0.62
Negative
0.66
Negative
Market Momentum
-0.03
Negative
34.99
Neutral
22.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CSX, the sentiment is Negative. The current price of 0.68 is above the 20-day moving average (MA) of 0.48, above the 50-day MA of 0.56, and above the 200-day MA of 0.66, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 34.99 is Neutral, neither overbought nor oversold. The STOCH value of 22.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:CSX.
CleanSpace Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | AU$24.72M | -1.40 | -98.14% | ― | 14.84% | 39.64% | |
45 Neutral | AU$34.66M | -1.41 | -165.13% | ― | 23.31% | -17.35% | |
44 Neutral | AU$104.49M | -6.27 | -54.48% | ― | 34.20% | -23.90% | |
44 Neutral | AU$145.91M | -10.00 | -70.29% | ― | ― | -257.32% | |
43 Neutral | AU$37.11M | 7.24 | 8.71% | ― | 25.72% | 84.69% | |
41 Neutral | AU$37.03M | -2.66 | -180.06% | ― | -14.25% | -22.83% |
* Healthcare Sector Average
AU:CSX
CleanSpace Holdings Ltd.
0.47
0.07
17.50%
AU:IPD
Impedimed Limited
0.02
-0.02
-51.43%
AU:CYC
Cyclopharm Limited
0.87
-0.26
-23.45%
AU:MX1
Micro-X Ltd.
0.05
>-0.01
-15.00%
AU:EMV
EMvision Medical Devices Ltd.
1.57
-0.23
-12.83%
AU:CBL
Control Bionics Ltd.
0.06
0.02
36.36%
CleanSpace Holdings Ltd. Corporate Events
CleanSpace Director Increases Shareholding as RSUs Convert and Lapse
Mar 10, 2026
CleanSpace Holdings has disclosed changes to director Graham McLean’s indirect interests, reflecting increased equity exposure through both on-market share purchases and the conversion of restricted stock units. The transactions, conducted v...
CleanSpace Seeks ASX Quotation for 37,500 New Ordinary Shares
Mar 10, 2026
CleanSpace Holdings Ltd., traded on the ASX as CSX, is an Australian-listed company that complies with ASX regulatory requirements in administering its ordinary fully paid shares. The business is positioned within the domestic capital markets and ...
CleanSpace Seeks ASX Quotation for 40,000 New Ordinary Shares
Mar 2, 2026
CleanSpace Holdings has applied for quotation of 40,000 new fully paid ordinary shares on the Australian Securities Exchange, with an issue date of 26 March 2026. The modest share issuance, arising from the exercise or conversion of existing secur...
CleanSpace outlines 1HFY26 results and cautions on forward-looking disclosures
Feb 25, 2026
CleanSpace Holdings has released its results presentation for the half year ended 31 December 2025, outlining its financial performance and operational developments for 1HFY26. The document emphasises that figures are prepared under IFRS, includes...
CleanSpace Delivers Margin-Strong H1 FY26 as Europe Drives Growth and Outlook Tightens
Feb 25, 2026
CleanSpace reported H1 FY26 revenue of $10.1 million, up 10% year on year, with gross margin improving to 75% and cash at bank rising 18% to $9.8 million, indicating sustained growth and strong unit economics. Operating EBITDA remained slightly ne...
CleanSpace Swings to Interim Profit on One-Off Loan Remeasurement Gain
Feb 25, 2026
CleanSpace Holdings Limited reported a strong turnaround for the half-year to 31 December 2025, with revenue from ordinary activities rising 9.7% to $10.1 million and net profit after tax swinging to $1.84 million from a $0.40 million loss a year ...
CleanSpace Secures $891,000 R&D Rebate to Drive Respiratory Tech Innovation
Feb 23, 2026
CleanSpace Holdings Limited, an Australian manufacturer of premium respiratory protection solutions for industrial and healthcare markets, continues to invest in advanced powered air purifying respirator technology developed by a team of biomedica...
CleanSpace seeks ASX quotation for new share issuance
Feb 23, 2026
CleanSpace Holdings has applied to the ASX for quotation of 490,530 additional ordinary fully paid shares, with an issue date of 17 February 2026. The move modestly increases the company’s free float and equity base, signalling ongoing capit...
CleanSpace Writes Off NSW Health Loan, Booking $2.8m Gain
Feb 22, 2026
CleanSpace Holdings has reclassified a $2.8 million funding loan from the NSW Health Administration Corporation, awarded under the Medical Device Funding program in 2019, from a long-term liability to nil on its balance sheet as at 31 December 202...
CleanSpace Issues 863,000 Unquoted Restricted Share Awards Under Employee Scheme
Feb 6, 2026
CleanSpace Holdings has notified the ASX that it has issued 863,000 unquoted restricted share awards under its employee incentive scheme. The new equity awards, which are not intended to be quoted on the exchange, represent a further use of stock-...
CleanSpace Sets Date for FY26 Half-Year Results Briefing
Feb 1, 2026
CleanSpace Holdings has scheduled the release of its half-year results for the period ended 31 December 2025 on 26 February 2026, with the chairman, CEO and CFO to brief investors and analysts via webcast and telephone. The planned briefing unders...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.